Plus, news about Oruka Therapeutics, Centessa, Takeda, Innate Pharma and Liquidia: GSK’s mRNA flu vaccine succeeds against both strains in Phase 2: The pharma company ...

The Parker Institute for Cancer Immunotherapy, a research network established by tech entrepreneur Sean Parker, announced a new $125 million investment. The latest investment comes from Parker and ...

Senate Finance Committee Chair Ron Wyden (D-OR) is urging HHS to take a stronger stance on healthcare companies' cybersecurity practices as the healthcare system is still piecing together what ...

Madri­gal Phar­ma­ceu­ti­cals is “mak­ing great progress” on the roll­out of its NASH drug Rezd­if­fra, ex­ec­u­tives said less than a month post-launch. Rezd­if­fra was ...

April 29, 2024 05:53 PM EDT Updated 06:48 PM ...

To help meet the heightened demand for its injectable products, Eli Lilly is acquiring a facility from Nexus Pharmaceuticals, with production anticipated to start at the end of next year ...

Just over three months into his new role as the CEO of Recipharm, Greg Behar is already making sizable changes to the CDMO’s engine. “I've been studying the company deeply ...

March 11, 2024 04:54 AM EDT Updated March 12, 06:55 PM ...

Reps. Kelly Armstrong (R-ND) and Ben Cline (R-VA) sent a letter last week to Attorney General Merrick Garland, asking why the Department of Justice is willing to incur potential patent ...

ARCH Venture Partners plans to raise $3 billion for its 13th fund, per a new SEC filing from this week. The Chicago-based venture capital firm has ...

Small molecule biotech Totus Medicines has closed a $66 million Series B to carry its PI3Kα inhibitor through Phase Ia and has named Nassim Usman as its new president and ...

Citius Phar­ma­ceu­ti­cals plans to re­file its ex­per­i­men­tal drug for a rare blood can­cer in ear­ly 2024 fol­low­ing an FDA re­jec­tion in Ju­ly. The drug … ...